What is NDC 0173-0956?

0173-0956 is the product NDC for Utebzi (tebipenem pivoxil), Tebipenem pivoxil hydrobromide 300 mg/1 tablet, film coated, listed with the FDA by GlaxoSmithKline LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

What is the active ingredient?

Tebipenem pivoxil hydrobromide.

GlaxoSmithKline LLC, NDC labeler code 0173. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Utebzi?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Utebzi NDC 0173-0956 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0173-0956Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00173-0956Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0173-0956-76	00173095676	10 BLISTER PACK in 1 CARTON (0173-0956-76) / 8 TABLET, FILM COATED in 1 BLISTER PACKMarketed from Oct 1, 2026

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Utebzi
Generic name (nonproprietary): tebipenem pivoxil
Active ingredients: Tebipenem pivoxil hydrobromide — 300 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: GlaxoSmithKline LLCNDC labeler code 0173
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 215960
Marketing start: Oct 1, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 0173-0956_f0511453-5f6f-4e3a-b7d0-a5cfde985656SPL ID f0511453-5f6f-4e3a-b7d0-a5cfde985656

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400173095676 followed by a unit qualifier and the quantity

Package 00173-0956-76. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 0173-0956

What is NDC 0173-0956?: 0173-0956 is the product NDC for Utebzi (tebipenem pivoxil), Tebipenem pivoxil hydrobromide 300 mg/1 tablet, film coated, listed with the FDA by GlaxoSmithKline LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Utebzi (Tebipenem Pivoxil).
What is the active ingredient?: Tebipenem pivoxil hydrobromide.
Who is the labeler?: GlaxoSmithKline LLC, NDC labeler code 0173. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Utebzi?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Utebzi (Tebipenem pivoxil) NDC 0173-0956